For English click here.
Feminismo, deficiência e autonomia reprodutiva: o aborto em tempos de Zika no Brasil
Introdução
Em novembro de 2015, após o anúncio de que o número de crianças nascidas com a condição clínica de microcefalia no nordeste do Brasil havia aumentado dramaticamente, o Ministério da Saúde do Brasil declarou emergência nacional em saúde pública (Diniz 2016a, …
This month, and especially this past week, has seen immense media coverage of abortion access, both in the United States and abroad. A recent study out of UCSF has shown that abortion is extremely safe, with lower post-procedure ER visits than many other routine surgical procedures. However, despite the safety of this medical procedure, abortion is still highly …
Jane started us off by saying “I grew up in the US, so I could never count on having healthcare.” Jane (for whom I’m using a pseudonym) is a midwife, dark hair pulled back in a low ponytail, with a warm look in her eyes. She’s holding a device that looks like a weird experiment, some combustion between a school …
In this response we address how the recent language controversy surrounding the Center for Disease Control and Prevention (CDC) must be considered as part of a broader politicisation of public health services used by women and minority groups in the US context, which has international implications given the influential position of the CDC in global health governance. Our individual areas …
On January 17th 2014, Catherine Eagles, a federal judge for the Middle District of North Carolina, struck down as unconstitutional a portion of North Carolina’s 2011 Women’s Right to Know Act. The portion in question would have required abortion providers in the state to perform an ultrasound and display and describe the images presented to every woman seeking an …
This month’s Web Roundup is dedicated to the role that legislation and the courts have in promoting or restricting access to medical care. In particular, I will focus briefly on the passage of anti-abortion legislation in the US and a few recent court cases that are testing the limits pharmaceutical patents. While not overtly theoretical in nature, I have found …